Significance of bFGF and VEGF in patients with gastric cancer;Znaczenie czynników bFGF i VEGF w surowicy krwi u chorych na raka zoła̧dka

Polski Przeglad Chirurgiczny

Volumn 74, Issue 12, 2002, Pages 1138-1144

  Wallner, Grzegorz ^a   Ciechański, Aleksander ^a   Da̧browski, Andrzej ^a   Ćwik, Grzegorz ^a   Roliński, Jacek ^a  

^a NONE

Author keywords

Angiogenesis; Basic Fibroblast Growth Factor; Gastric carcinoma; Vascular Endothelial Growth Factor

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; VASCULOTROPIN;

ADULT; ARTICLE; BLOOD LEVEL; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME IMMUNOASSAY; EVALUATION; FEMALE; FISHER EXACT TEST; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; MEASUREMENT; PROGNOSIS; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; STOMACH ADENOCARCINOMA; STOMACH CANCER;

EID: 17144457400     PISSN: 0032373X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Radzikowski Cz, Opolski A, Wietrzyk I: Znaczenie angiogenezy w dynamice wzrostu nowotworu. Post Hig Dośw 1998; 52(6): 533-76.
2. Folkman J: Clinical applications of research on angiogenesis. N Eng J Med 1995; 333: 1757-63.
3. Hanahan D, Folkman J: Patterns and energing mechanisms of the angiogenic switch during tumor-genesis. Cell 1996; 86: 353-64.
4. Liotta LA, Stracke ML: Tumor invasion and metastasis: Biochemical mechanisms. Cancer Treat Res 1998; 40: 223-38.
5. Poon R, T-P, Fan S-T, Woong J: Clinical implications of circulating angiogenetic factors in cancer patients. J Clin Onc 2001; 19(4): 1207-25.
6. Saito H, Tsujitani S, Oka S i wsp.: The expression of transforming growth factor-beta 1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma. Cancer 1999; 86: 1455-62.
7. Saito H, Tsujitani S, Kondo A i wsp.: Expression of vascular endothelial growth factor correlates with hematogenous recurrence in gastric cancer. Surgery 1999; 125: 1995-2001.
8. Ueki T, Koji T, Tamiya S i wsp.: Expression of basic fibroblast growth factor and fibroblast growth factor receptor in advanced gastric carcinoma. J Pathol 1995; 177: 353-61.
9. Yoshikawa T, Tsuburaya A, Kobayashi O i wsp.: Plasma concentration of VEGF and bFGF in patients with gastric carcinoma. Cancer Lett 2000; 153: 7-12.
10. Spiessl B, Beahrs OH, Hermanek P i wsp. Atlas TNM. Ilustrowany przewodnik po klasyfikacji TNM/pTNM nowotworów złośliwych. Sanmedica, Warszawa 1994; 71-81.
11. Folkman J: What is the evidence that tumors are angiogenesis dependent. J Natl Cancer Inst 1990; 82: 4-6.
12. Weinder N, Folkman J, Pozza F i wsp.: Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma J Natl Cancer Inst 1992; 84: 1875-87.
13. Kumar H, Heer K, Lee PW i wsp.: Preoperative serum vascular endothelial growth factor in patients with colorectal cancer. Clin Cancer Res 1998; 4: 1279-85.
14. Hyodo I, Doi T, Endo H i wsp.: Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer. Eur J Cancer 1998; 34: 2041-245.
15. Poon RTP, Ng IOL, Lau C i wsp.: Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma. A prospectiva study. Ann Surg 2001; 233: 227-35.
16. Kitamura M, Toi M, Arai K i wsp.: Concentration of vascular endothelial growth factor in the sera of gastric cancer patients. Oncol Rep 1998; 5: 1419-24.
17. Eroglu A, Demirci S, Ayyildiz A i wsp.: Serum concetration of vascular endothelial growth factor and nitrite as a estimate of in vivo nitric oxide in patients with gastric cancer. Br J Cancer 1999; 80: 1630-34.
18. Maeda K, Chung Y-S, Ogawa Y i wsp.: Prognostiv value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 1996; 77(5): 853-63.